ࡱ> 79  !"#$%&'()*+,-./0123456:Root Entry Fp\8WorkbookiSummaryInformation(DocumentSummaryInformation8 \ppriyaKrasnova Ba==h,x< 8X@"1Calibri1Calibri1Calibri1Calibri1Calibri1 Calibri1Calibri14Calibri1 Calibri1Calibri1Calibri1,8Calibri18Calibri18Calibri1>Calibri14Calibri1<Calibri1?Calibri1h8Cambria1Calibri1 Calibri1Calibri1hCalibri1@Calibri1Calibri1Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)                                                                       ff + ) , *     P  P        `            a>         8  8     d  (@ @   ,  ,@ @   (@ @   ,@ @   (@ @    d@ @    d@ @    d@ @    d@ @   "|@ @    d@ @    d@ @  8@ @  8@ @  8@ @  <@ @  <@ @  <@ @  x@ @  x@ @  x@ @  x@ @  ||\Wl}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-} 00\);_(*}-} 00\);_(*}A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef ;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L ;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A}  00\);_(*23;_(@_) }A}! 00\);_(*23 ;_(@_) }A}" 00\);_(*;_(@_) }A}# 00\);_(*;_(@_) }A}$ 00\);_(*;_(@_) }A}% 00\);_(*;_(@_) }A}& 00\);_(*;_(@_) }A}' 00\);_(* ;_(@_) }A}( 00\);_(*;_(@_) }}) }00\);_(*;_(@_)    }}* 00\);_(*;_(@_) ??? ??? ??? ???}-}+ 00\);_(*}-}, 00\);_(*}-}- 00\);_(*}-}. 00\);_(*}-}/ 00\);_(*}A}0 a00\);_(*;_(@_) }A}1 00\);_(*;_(@_) }A}2 00\);_(*?;_(@_) }A}3 00\);_(*23;_(@_) }-}4 00\);_(*}}5 ??v00\);_(*̙;_(@_)    }A}6 }00\);_(*;_(@_) }A}7 e00\);_(*;_(@_) }}8 00\);_(*;_(@_)    }}9 ???00\);_(*;_(@_) ??? ??? ??? ???}-}: 00\);_(*}-}; 00\);_(*}U}< 00\);_(*;_(@_)  }-}= 00\);_(*}-}> 00\);_(*}}?}}@}-}A 00\);_(*}-}B 00\);_(*}}C}-}D 00\);_(*}}E}}F}}G}}H}}I}}J}-}K 00\);_(*}-}L 00\);_(*}-}M 00\);_(*}-}N 00\);_(*}-}O 00\);_(*}-}P 00\);_(*}-}Q 00\);_(*}}R}}S}}T}}U}}V}}W}-}X 00\);_(*}-}Y 00\);_(*}-}Z 00\);_(*}-}[ 00\);_(*9   !%9   !% 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L湸 % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  Lմ % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23ٗ % 60% - Accent3M( 60% - Accent3 23֚ % 60% - Accent4M, 60% - Accent4 23 % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23 % "Accent1AAccent1 O % #Accent2A!Accent2 PM % $Accent3A%Accent3 Y % %Accent4A)Accent4 d % &Accent5A-Accent5 K % 'Accent6A1Accent6  F %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 I}%O2 Heading 2G Heading 2 I}%?3 Heading 3G Heading 3 I}%234 Heading 49 Heading 4 I}% 5InputuInput ̙ ??v% 6 Linked CellK Linked Cell }% 7NeutralANeutral  e%3Normal % 8Noteb Note   9OutputwOutput  ???%????????? ???:$Percent ;Title1Title I}% <TotalMTotal %OO= Warning Text? Warning Text %XTableStyleMedium9PivotStyleLight16`F<Suppl. Table 3}A:CSLAGsADCancerPValuePathways # of sets*:* The number of sets in which a given pathway is enriched Type 2 diabetesPathways in cancerChronic myeloid leukemiaMelanomaPancreatic cancerProstate cancerEndometrial cancerMAPK signaling pathwayAcute myeloid leukemiaColorectal cancerNeurotrophin signaling pathwayInsulin signaling pathwaymTOR signaling pathway ApoptosisBladder cancerp53 signaling pathwayGliomaSmall cell lung cancerThyroid cancer$Toll-like receptor signaling pathwayFocal adhesion Cell cycleNon-small cell lung cancerRenal cell carcinomaErbB signaling pathwayPrion diseases)Natural killer cell mediated cytotoxicityVEGF signaling pathway'Progesterone-mediated oocyte maturation!T cell receptor signaling pathwayChemokine signaling pathwayViral myocarditisFc epsilon RI signaling pathwayTGF-beta signaling pathway,Intestinal immune network for IgA productionGnRH signaling pathwayLong-term depressionOocyte meiosis!B cell receptor signaling pathway Melanogenesis Gap junctionNon-homologous end-joiningDorso-ventral axis formationLong-term potentiation Regulation of actin cytoskeletonWnt signaling pathwayOxidative stressAthScChronic inflamXSupplementary Table 3. Pathways enriched across CS, ARDs and aging-associated processes.B16 6J7%889x:[:;ccB  3CZe  dMbP?_*+%,&?'?(?)?M"HP LaserJet P1005DdXXHP LaserJet P1005  ld'4@ @ dd@ "dXX333333?333333?&<3U} &@} I ?}  D3   ,> ,> ,> , , , , , , , , , , , , , , , , , , , , , , , , , , , , A9B R U Z Z Z7 X X Z X6  X8SV[[[YY[YY TW O O O O O O O  O H #I @ % BK%2;LqpHJrԀ?Llq;Ld̑\>L'֧w3>LB42=~0Lx S< L'֧w3> E #F @ % BM Jq<N+DP?NZ0>N q?NҬcH?NH:N%Xb= Nhl? E F @06 -BMRj=NYx?N)=N۴Q ?NS`>NAi)a?<No;= N7N7?NYjtN?N!Fr:Nv9g= N!Zʛ>> E F @ M>ܑdz=No?L>NwW` =NZ2{ F?NG- >Nzީ:NvU< NtA ZBc? E F @  M*ʟ*'F> NW No}g? NJ!yڔ? NbE\< Nt0= N^7Nֲ? E F@  Mt=t'> N ND`;]A> NPν? N=k ?r? N4gV; NЧR= Nv4Z? E F@  M%7.̿d> N;tE? N @V҄=? N NOd? NLJ0< N|]'@> NOd? E F@  M> N6WRP? N)|N= N Q=? NY7Z? N$$; N#".|= N E F@ Mfn> Nڋ{? N؄O? N N1S? Nn3; NֻPR= N~v? EF@M@ծ}S?N:9^>NZ1?N*vR?N1n=N+=N N EF@M$:g?Np`0'?N0Jr?NK?Ng-E ?NޜH C>Nxu> N EF@MTؠ?NN ku6?ND;?N@p`?NbɸWd>NVy> NAsh> EF@MM#^;NNG<1=NNQz?NLm<N-3?U> N쪍H? EF@MLd;NyNN[L:?Nxl*=N6> N EF@(M}zu<Ny?E?N+ڐe=NN/@>Nf3A|<Nȥ%= N EF@(M>NNL?NNY7Z?N~g#=N2> N^FKz? EF@(Mr9>NNS(^v?Nm(%?NND:j=Nxa#? Nb啳? EF@(MYOz>NN&_I)?NNfI?N#JGON>N=ۨvk> N6ݖ4= EF@(M/80?NNw54A)=N |?NߖК?N0M<NRW?yT> N EF@(M3G<NN ? NNN^ {a3<N!uv.pH? N EF@(McYX!=N6Euv?N]4é&? NNN>7<NU9> N EF@(Mn zE2>NN kMX>NN-bncc?N ֲő;Nͨ@A> N E F@(MWu>NN3%?NN@?N<N0= N E!F@(Ml?NN|&?N^h_?NNDWY?N#1? N E"F@(M*v?NNhM +? NNN7<?N^6xNp? Negpe? E#F@(MZR *?NN;hh?NNhl?Nl>N">TMmZt> N E$F@( M>xƴjB?NR9FG:? NNN4l?NpLš>Nʌu> ND)l*~ ,! ," ,# ,$ ,% ,& ,' ,( ,) ,* ,+ ,, ,- ,. ,/ ,0 ,2 ; E% F@(! MP颳YH? N N_)&17? NN N u3< N4$s> NZ> !E&!F@("!Mc^?!N!Nf L>? !NN!N_RJp>!N2>! Nԙn= "E'"F@(#"MPա?"N:m\Q(?"NC.f`? "NN"N{?"N" N7#N#NIϢ? #NN#NCK">#NT{$># N $E)$F@(%$M(km ?$N$N3%? $NN$N*n=$Nrj5?$ N %E*%F@(&%Mvcuz?%N%N=c> %NN%NŸY?%N% N~EXOd> &E+&F@('&M0?&NNNN&NT R>?&N +>& N 'E,'F@(('M\kB?'NO/I ?'NNNN'NrL|?' N (E-(F@()(MYI!L?(NyEț? (NNN(NpY}:? (NN )E.)F@(*)M/FP?)NNNN)NPỈ>)N\12tS>) N *E/*F@+*MnIw?*NNNN*Nm@?*Nsgun?* N +E0+F@,+M/(AQ?+N6ո?+NNNN+Nu=?+ N ,E1,F@-,M/~?,N:/!? ,NNN,N"+}?ȗ? ,NN -E2-F@.-MpD@?-NNNN-N8 P? -NN .E3.F@/.M*A?.NNNNN.Nr=?. N /E4/F@0/M y?/NNNN/Nd > /NN 0J50G@0P:_8?0QQQQ0Q-pV? 0QQ 2C(W Tqoqq>@ZQR   R  (; %@LAZ LAA&B$(; %@LAZ LAA&B${{; 4" ]|{{; 4" ]|ggD  Oh+'0HP`p RobivadimMicrosoft Excel@<*@Q̮@ܱ՜.+,0HP X`hp x  Suppl. Table 3  WorksheetsCompObjr F&Microsoft Office Excel 2003 WorksheetBiff8Excel.Sheet.89q